Physician

Melissa Ixcamey, M.D.

According to 2025 Medicare claims, Melissa Ixcamey, M.D. (NPI: 1245761055) practices ophthalmology in the Greenville-Anderson-Greer, SC market, with the plurality of this provider's patient population coming from Greenville, SC. This provider's primary affiliated billing organization is SOUTHERN EYE ASSOCIATES OF SOUTH CAROLINA, PA (NPI: 1215933510; TIN: 57-0563896) and primary practice location at 29650-2445. Ixcamey is affiliated with the CVS Accountable Care Organization, Inc. (ACO ID: D0061), participating under the REACH model.

Ixcamey's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 778 traditional Medicare patients, billed 10,964 HCPCS/CPT codes, and received $684,522 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 504 prescription claims across 198 beneficiaries totaling $30,901 in drug costs, led by Combigan (Brimonidine Tartrate/Timolol). Open Payments data shows 9 records totaling $230. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $141 and ending at $30,901. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$342K$685K2021 Medicare payment: $99,909 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $265,955 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $319,608 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $684,522 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021178627$99,909
20223761,910$265,955
20234133,759$319,608
202477810,964$684,522

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$52K$103K2017 Drug cost: $141 (USD; Tot_Drug_Cst)2018 Drug cost: $6,686 (USD; Tot_Drug_Cst)2019 Drug cost: $34,485 (USD; Tot_Drug_Cst)2020 Drug cost: $25,979 (USD; Tot_Drug_Cst)2021 Drug cost: $32,833 (USD; Tot_Drug_Cst)2022 Drug cost: $103,405 (USD; Tot_Drug_Cst)2023 Drug cost: $72,572 (USD; Tot_Drug_Cst)2024 Drug cost: $30,901 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R12$141
201863163$6,686
2019139555$34,485
2020123446$25,979
2021182479$32,833
20223051,077$103,405
2023258729$72,572
2024198504$30,901

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye156492$90
92004New patient complete exam of visual system121121$89
92014Established patient complete exam of visual system592900$86
92134Imaging of retina420775$29
92250Photography of the retina347448$25

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CombiganBrimonidine Tartrate/Timolol15741$5,457
Prednisolone AcetatePrednisolone Acetate862,874$3,453
Azelastine HclAzelastine Hcl281,276$828
ErythromycinErythromycin Base811,696$750
Brimonidine TartrateBrimonidine Tartrate17727$634

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.9$230ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Melissa Ixcamey, M.D.?

Tedicare shows public-source Medicare data for Melissa Ixcamey, M.D. (NPI 1245761055), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Melissa Ixcamey, M.D. have ACO affiliation data?

Melissa Ixcamey, M.D. is shown with ACO affiliation data for CVS Accountable Care Organization, Inc. (REACH, ACO ID D0061).

What billing organization is linked to Melissa Ixcamey, M.D.?

Melissa Ixcamey, M.D. is linked to SOUTHERN EYE ASSOCIATES OF SOUTH CAROLINA, PA (billing NPI 1215933510) in the available physician profile data.

Does Melissa Ixcamey, M.D. have Open Payments data?

Melissa Ixcamey, M.D. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.